We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn about our cookie policy.
Cayman INCB 057643


Product Description
INCB 057643 is a bromodomain and extra terminal domain (BET) family protein inhibitor.1 It inhibits binding of bromodomain-containing protein 2 (BRD2), BRD3, and BRD4 to an acetylated histone H4 peptide in vitro. INCB 057643 decreases Myc levels in, and inhibits proliferation of, acute myeloid leukemia (AML), diffuse large B cell lymphoma (DLBCL), and multiple myeloma (mm) cells. In vivo, INCB 057643 reduces tumor growth in AML, DLBCL, and mm mouse xenograft models. It also reduces tumor growth when administered alone or in combination with docetaxel (Item No. 11637) or enzalutamide (MDV 3100; Item No. 11596) in a 22Rv1 castration-resistant prostate cancer (CRPC) mouse xenograft model.2
WARNING This product is not for human or veterinary use.
Technical Information
- DMF: 30 mg/mL
- DMSO: 30 mg/mL
- DMSO:PBS (pH 7.2) (1:6): 0.14 mg/mL
Shipping & Storage Information
| SKU | CAYM-31456-5 |
|---|---|
| Supplier Part Number | 31456-5 |
| UM | EA |
| UNSPSC | 12352200 |
| Manufacturer | Cayman |
| MSDS URL | Click here |
| Temperature | -20 |
| Refrigerated-Frozen | Y |
| CountryOfOrigin | United States |
| ProductLine | CAYM |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 7.000000 |
| Lead Time | 5 |
| Hazardous | N |
| CAS Number | 1820889-23-3 |
| Energy Star | No |
| Green | No |
| Controlled | N |

